OKUR compared with AVR: revenue, margins and what each company keeps, and the suppliers and customers both name

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

AVRAnteris Technologies Global Corp.

Mkt capRevenueRevenue

Compare

OKUROnKure Therapeutics, Inc.

AVRAnteris Technologies Global Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OKUR1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±80.0%▲+1.46%×0.02

AVR

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−3.27%—

May 13 '26±12.1%▼−2.54%×0.21

= impliedOKUR realized, solidAVR realized, hatchedOne scale, both sides: full bar = 80%× = |realized| ÷ impliedSource: market data

Q1 FY26

±26.5%

▲+2.68%

×0.10

Q3 FY25—▼−2.57%—

OKUROnKure Therapeutics, Inc.

2.60▼−0.58%· post 2.60· delayed

Mkt cap$106.1MRevenue—Revenue—

AVRAnteris Technologies Global Corp.

5.80▼−8.04%· post 5.89· delayed

After hoursNov 2 '26delayed

Mkt cap$615.0MRevenue$1MQ2 FY26Revenue$2MFY25

Compare

After hoursNov 2 '26delayed

OKUROnKure Therapeutics, Inc.

AVRAnteris Technologies Global Corp.

2.60▼−0.58%post 2.60delayed

Price

5.80▼−8.04%post 5.89delayed

$106.1M

Mkt cap

$615.0M

—

Revenue

$1MQ2 FY26

—

Revenue

$2MFY25

OKUR2.60▼−0.58%vsAVR5.80▼−8.04%After hoursNov 2 '26delayed